The Leadership Team at GenSight Biologics is responsible for setting the strategic direction and overseeing the operations of the company. Comprised of key executives including the CEO, CFO, and COO, as well as heads of various departments, this team ensures the alignment of company goals, drives business development, manages financial health, and oversees the development and regulatory approval of gene therapy treatments for retinal degenerative diseases.
Clémentine Ravache
Deputy Chief Financial Officer
Julio Benedicto
VP of Strategic Marketing
Magali Taiel
Chief Medical Officer
Marion Ghibaudo
CTO, Medical Device
Micheline Wille
VP Medical Affairs
Philippe Motté
SVP, Regulatory & Quality
Scott Jeffers
CTO
Sissel Rodahl
SVP, Commercial Operations
Thomas Gidoin
CFO
View all